COMMUNIQUÉS West-GlobeNewswire

Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli

18/12/2017 - 16:16

ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 17.15 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli Orion Corporation has received the following disclosure under Market Abuse [...]

Emblem Corp. Launches Leading Line of Cannabis Oils to Meet Growing Demand and Drive Patient Acquisition

18/12/2017 - 16:13

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) , one of the [...]

The Painful Side Effect to Gifting Gadgets this Holiday Season

18/12/2017 - 16:00

SCOTTSDALE, Ariz., Dec. 18, 2017 (GLOBE NEWSWIRE) -- If you have a new phone or the latest video game console wrapped beneath your tree, you may also be giving a painful gift to your loved ones this holiday season. Text [...]

The Painful Side Effect to Gifting Gadgets this Holiday Season

18/12/2017 - 16:00

ALBUQUERQUE, N.M., Dec. 18, 2017 (GLOBE NEWSWIRE) -- If you have a new phone or the latest video game console wrapped beneath your tree, you may also be giving a painful gift to your loved ones this holiday season. Text [...]

Coloplast acquires SAS Lilial

18/12/2017 - 15:28

Today Coloplast A/S acquires the French direct-to-consumer home delivery company SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m. Lilial is a privately owned, French direct-to [...]

Announcement no. 13/2017 - Coloplast A/S acquires SAS Lilial

18/12/2017 - 15:27

Coloplast A/S acquires SAS Lilial Coloplast A/S announced today that it has entered into a definitive agreement to acquire SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m on a cash [...]

Board of Olainfarm Will be Chaired by Olegs Grigorjevs

18/12/2017 - 15:27

Olaine, 2017-12-18 15:27 CET (GLOBE NEWSWIRE) -- Olegs Grigorjevs was Executive Director of AS Olainfarm and the Member of the Board with more than 20 years of experience in chemical and pharmaceutical sector. O. [...]

PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018

18/12/2017 - 15:15

NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]

Advantis Corp. Expects Quarterly Revenue Records Throughout 2018

18/12/2017 - 15:15

Newport Beach, CA , Dec. 18, 2017 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT ) CEO, Darren Cherry, took a moment to review the progress the company has made this year, and lays out an achievable set of [...]

Orion Corporation: Managers' transactions - Huhta-Koivisto Tero

18/12/2017 - 15:00

ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 16.00 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Tero Orion Corporation has received the following disclosure under Market Abuse [...]

La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC‑401 in Patients with Hereditary Hemochromatosis

18/12/2017 - 15:00

SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (NASDAQ: LJPC ) (the Company or La Jolla) today announced the initiation of LJ401-HH01, a Phase 2 clinical study of LJPC‑401 (synthetic human [...]

athenahealth to Present at the 36th Annual J.P. Morgan Healthcare Conference

18/12/2017 - 15:00

WATERTOWN, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that Jonathan Bush, [...]

Orion Corporation: Managers' transactions - Huhta-Koivisto Kalle

18/12/2017 - 14:51

ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 15.50 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Kalle Orion Corporation has received the following disclosure under Market Abuse [...]

Orion Corporation: Managers' transactions - Huhta-Koivisto Esko kuolinpesä

18/12/2017 - 14:46

ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 15.45 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Esko kuolinpesä Orion Corporation has received the following disclosure under Market [...]

RespireRx Pharmaceuticals Inc. Publishes Compelling Scientific Evidence Demonstrating the Neurobiological Safety of Ampakine CX717 and Justifying Continued Clinical Development

18/12/2017 - 14:45

Glen Rock, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that a paper detailing the neurobiologic safety of the ampakine [...]

United Health Products Completes Multiple FDA Required Tests for HemoStyp®

18/12/2017 - 14:30

HENDERSON, Nev., Dec. 18, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

EyeGate Achieves 75% Enrollment in Pivotal Phase 3 Clinical Trial for Anterior Uveitis Triggering Milestone Payment

18/12/2017 - 14:30

WALTHAM, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for [...]

Ultragenyx Sells Priority Review Voucher for $130 million

18/12/2017 - 14:30

NOVATO, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

New Biomarker Data Supports Direct Link between VB-111’s Dual Mechanism of Action and its Clinical Effect on Overall Survival and Progression Free Survival in Recurrent Glioblastoma Multiforme Patients

18/12/2017 - 14:28

TEL AVIV, Israel, Dec. 18, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), announced new biomarker data supporting the direct link between lead asset VB-111’s dual mechanism of action and clinical effect on [...]